In line with this, the activation of Nrf2 and its targets genes such as HO-1 and NOQ1 ameliorates kidney damage by decreasing the p65 NF-κB subunit along with the priming of NLRP3 [258,259]. The gene discussed is NLRP3; the disease is Nephropathy.